Catalyst Wire Dossier Catalyst Wire Dossier
FDA label_change · 2009-05-20

FDA Approved: ZESTORETIC — Supplemental Application (Almatica Pharma Inc.)

View source ↗

Summary

The FDA approved a supplemental application for ZESTORETIC (lisinopril and hydrochlorothiazide) from Almatica Pharma Inc., resulting in changes to the product l…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ZESTORETIC (LISINOPRIL AND HYDROCHLOROTHIAZIDE)

Snippet

SUPPL AP for ZESTORETIC (LISINOPRIL AND HYDROCHLOROTHIAZIDE)